摘要
目的比较直接经皮冠状动脉介入治疗（PCI）与常规药物治疗急性冠脉综合征患者的近期临床疗效对比分析。方法选取2011年12月至2013年7月急性冠脉综合征患者134例，根据是否行介入治疗分为药物组（68例）和PCI组（66例）。对比出院后18个月内两组主要不良心脏事件及再次住院率。结果PCI组再次住院率、再发心力衰竭发生率、再次血管重建、再发急性心肌梗死明显低于药物组，差异有统计学意义（P〈0．05）。结论急性冠脉综合征直接PCI治疗优于药物治疗，近期疗效明确，具有较强的临床推广价值。
Objective To compare the clinical effect between percutaneous coronary intervention （ PCI ） and regular medicine treatment in patients of acute coronary syndrome. Methods 134 patients were recruited in this research including 68 cases with medicine treatment and 66 cases with PCI. Major adverse cardiac events were compared when 18 months later after discharge. Results The rates of rehospitalization, recurrence of heart failure, revascularization and recurrence of myocardial infarction of PCI group were lower than those of medicine group, with significant difference. Conclusions The effect of direct PCI is better than that of medicine treatment and should be extended in clinical practice.
出处
《浙江临床医学》
2016年第4期657-658,共2页
Zhejiang Clinical Medical Journal
关键词
急性冠脉综合征
直接PCI
药物治疗
对比分析
Acute coronary syndrome Direct PCI Medicine treatment Comparison analysis
